Full Press Release Details
Myomo Reports Second Quarter 2025 Financial and Operating Results
Revenue of $9.7 million
816 patients added to the MyoPro pipeline
Updates 2025 revenue guidance
Conference call begins today at 4:30pm Eastern time
BURLINGTON, Mass. (August 11, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and six months ended June 30, 2025.
Financial and operating highlights for the second quarter of 2025 include the following (all comparisons are with the second quarter of 2024 unless otherwise indicated): Read more.